https://cmhc.amerra.com/cardiorenalmonograph/2020-11-10T16:39:49+00:00https://cmhc.amerra.com/about-me/2020-05-20T13:07:12+00:00https://cmhc.amerra.com/contact/2020-05-25T14:23:00+00:00https://cmhc.amerra.com/2020-05-26T11:32:27+00:00https://cmhc.amerra.com/sample-page-2/2020-05-19T08:07:17+00:00https://cmhc.amerra.com/chapter-i-the-relationship-between-hf-ckd-and-t2dm/2020-10-26T16:20:34+00:00https://cmhc.amerra.com/elementor-381/2020-09-23T21:49:30+00:00https://cmhc.amerra.com/chapter-2-translating-the-evidence-patient-cases/2020-11-18T19:42:12+00:00https://cmhc.amerra.com/chapter-iii-clinical-pearls/2020-10-21T19:35:56+00:00https://cmhc.amerra.com/chapter-iv-additional-resources-for-healthcare-providers/2021-09-15T17:59:56+00:00https://cmhc.amerra.com/chapter-v-news-digest/2021-10-05T20:47:18+00:00https://cmhc.amerra.com/references/2020-11-06T19:44:55+00:00https://cmhc.amerra.com/article-submission/2020-11-10T16:42:16+00:00https://cmhc.amerra.com/chapter-i-the-relationship-between-hf-ckd-and-t2dm/cardiovascular-outcomes-trials-with-sglt-2-inhibitors/2020-10-21T19:24:07+00:00https://cmhc.amerra.com/chapter-i-the-relationship-between-hf-ckd-and-t2dm/sglt-2-inhibitors-and-heart-failure/2020-10-21T18:32:59+00:00https://cmhc.amerra.com/chapter-i-the-relationship-between-hf-ckd-and-t2dm/sglt-2-inhibitors-and-chronic-kidney-disease/2020-10-21T18:33:43+00:00https://cmhc.amerra.com/chapter-i-the-relationship-between-hf-ckd-and-t2dm/current-guidelines-and-recommendations/2020-10-21T19:36:56+00:00https://cmhc.amerra.com/chapter-i-the-relationship-between-hf-ckd-and-t2dm/conclusions/2020-10-26T16:21:02+00:00https://cmhc.amerra.com/chapter-2-translating-the-evidence-patient-cases/case-1/2021-12-10T03:40:03+00:00https://cmhc.amerra.com/chapter-2-translating-the-evidence-patient-cases/case-2/2021-12-10T03:54:30+00:00https://cmhc.amerra.com/chapter-2-translating-the-evidence-patient-cases/case-1-part-2/2021-12-10T03:40:38+00:00https://cmhc.amerra.com/chapter-2-translating-the-evidence-patient-cases/case-1-part-3/2021-12-10T03:48:24+00:00https://cmhc.amerra.com/chapter-2-translating-the-evidence-patient-cases/case-1-part-4/2020-10-26T16:25:28+00:00https://cmhc.amerra.com/chapter-2-translating-the-evidence-patient-cases/case-2-conclusion/2020-10-26T16:23:14+00:00